Drug class
Anthracycline Topoisomerase Inhibitor
Mechanism of action
Topoisomerase Inhibitors
General use cases
- Breast Neoplasms
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid, Acute
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
